CARTITUDE-5

Phase 3, Randomized Study comparing Bortezomib, Lenalidomide, and Dexamethasone (VRd) followed by an investigational CAR-T versus VRd followed by Lenalidomide and Dexamethasone (RD)Therapy in subjects with newly diagnosed Multiple Myeloma for whom Stem Cell Transplant is not planned as initial therapy

What's the purpose of the trial?

This trial is comparing the safety and efficacy of VRd followed by an investigational CAR-T cell therapy versus VRd and Rd in participants with newly diagnosed multiple myeloma.

Trial status

Active, Not Recruiting

Phase
Phase 3
Enrollment
650
Last Updated
1 week ago
Am I Eligible

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.